Avilex Pharma

Investment area
Novo Seeds
Region
Europe
Date of investment
February 2013

Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.

Avilex Pharma

Investment area
Novo Seeds
Region
Europe
Date of investment
February 2013

Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.

Avilex Pharma

Investment area
Novo Seeds
Region
Europe
Date of investment
February 2013

Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.